Clinical Trial Update: Safety and Efficacy Study of Glufosfamide in Previously Treated Advanced Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

This clinical trial update reports Phase 2 results for glufosfamide in previously treated advanced soft tissue sarcoma, focusing on safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Glufosfamide (glufosfamide)

Snippet

Sponsor: Eleison Pharmaceuticals LLC. | Conditions: Soft Tissue Sarcoma | Phase 2 | Status: COMPLETED | Results posted: 2015-03-02